BiotechTube

ABT-450/r/ABT-267

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Absolute Bioavailability

Conditions

Absolute Bioavailability

Trial Timeline

Jan 1, 2014 → Feb 1, 2014

NCT ID
NCT02052362

About ABT-450/r/ABT-267

ABT-450/r/ABT-267 is a phase 1 stage product being developed by AbbVie for Absolute Bioavailability. The current trial status is completed. This product is registered under clinical trial identifier NCT02052362. Target conditions include Absolute Bioavailability.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02052362Phase 1Completed

Other Products from AbbVie

Pancrelipase + PancrelipaseApproved
85
CREONApproved
85
Venetoclax + AzacitidineApproved
85
Oxybutynin + PlaceboApproved
85
Glecaprevir-pibrentasvirApproved
85